APP下载

载体介导shRNA对胃癌细胞株MKN45中C—met的抑制作用

2016-02-20黄志盛何海萍梁锐彬

中国实用医药 2016年5期
关键词:胃癌

黄志盛 何海萍 梁锐彬

【摘要】 目的 探讨载体介导短发夹核糖核酸(shRNA)对胃癌细胞株MKN45中原癌基因C-met的抑制作用。方法 9株胃癌细胞株分为转染组、阴性对照组和空白对照组, 各3侏。通过实时荧光定量逆转录-聚合酶链反应(RT-PCR)技术, 观察转染24 h和48 h后, 原癌基因C-met的信使核糖核酸(mRNA)的CT值的变化;通过免疫印迹试验(Western blot), 观察转染后C-met的蛋白变化;通过四氮唑盐MTT比色法, 计算细胞存活率。结果 载体介导的C-met shRNA转染24 h和48 h后, RT-PCR结果显示, C-met的mRNA抑制率分别为56%和88%;与空白对照组比较, C-met的蛋白表达水平明显下降, 转染后24 h [(0.812±0.105) VS (0.640±0.011)]、48 h[(0.811±0.103) VS (0.331±0.009)], 差异均有统计学意义(P<0.05);MTT比色法显示, 细胞存活率均有明显下降, 转染后24 h为65.9%, 48 h为59.6%。结论 载体介导的C-met shRNA不仅可降低胃癌细胞株MKN45中原癌基因C-met的mRNA及其蛋白表达水平, 而且对癌细胞的存活有明显的抑制作用。

【关键词】 载体介导;胃癌;信使核糖核酸;原癌基因C-met

DOI:10.14163/j.cnki.11-5547/r.2016.05.015

Inhibiting effect by vector-mediated shRNA on C-met in stomach cancer cell strain MKN45 HUANG Zhi-sheng, HE Hai-ping, LIANG Rui-bin. Department of Gastroenterology, Guangzhou City Panyu District Shawan Peoples Hosptal, Guangzhou 511400, China

【Abstract】 Objective To investigate inhibiting effect by vector-mediated short hairpin RNA (shRNA) on proto-oncogene C-met in stomach cancer cell strain MKN45. Methods A total of 9 stomach cancer cell strains were divided into transfection group, negative control group and blank control group, with 3 strains in each group. Real-time fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR) was applied to observe changes of CT value of messenger ribonucleic acid (mRNA) in proto-oncogene C-met after 24 and 48 h of transfection. Western blot was used to observe changes of protein in C-met after transfection. Tetrazolium-based colorimetric assay (MTT) was applied to calculate cell survival rate. Results In 24 and 48 h after vector-mediated mRNA shRNA transfection, RT-PCR showed mRNA inhibition rates by C-met were respectively 56% and 88%. Comparing with the blank control group, C-met had obviously reduce protein expression level, as [(0.812±0.105) VS (0.640±0.011)] in 24 h after transfection and [(0.811±0.103) VS (0.331±0.009)] in 48 h after transfection. Their differences all had statistical significance (P<0.05), MTT showed obviously decreased cell survival rate, as 65.9% in 24 h after transfection and 59.6% in 48 h after transfection. Conclusion Vector-mediated C-met shRNA can not only reduce mRNA and its protein expression in proto-oncogene C-met of stomach cancer cell strain MKN45, and also show remarkable inhibiting effect for survival of cancer cell.

【Key words】 Vector-mediated; Stomach cancer; Messenger ribonucleic acid; Proto-oncogene C-met

据Roder[1]报道, 我国为胃癌的高发地区。有研究发现[2], RNA干扰是人为引入与内源靶基因具有相同序列双链RNA, 诱导内源靶基因的mRNA降解, 达到阻止基因表达的目的。现将研究结果报告如下。

1 材料与方法

1. 1 材料 胃癌细胞株MKN45购自上海市消化疾病研究所(共9株);实时荧光定量聚合酶链反应试剂盒购自美国Promega公司;小鼠抗人β-肌动蛋白(β-actin)一抗、小鼠抗人C-met一抗、辣根过氧化物物酶标记兔抗小鼠二抗购自美国Santa Cruz公司; C-met shRNA和阴性对照购自美国OPEN-BIOSYSTEMS公司。

1. 2 方法 实验分组:转染组(转染shRNA)、阴性对照组(转染错义序列)和空白对照组(未转染shRNA), 各3株。细胞转染, RT-PCR检测各组的C-met的 mRNA表达, 读取每孔的CT值[3, 4], 计算各分组目的基因相对定量值。Western blot法检测C-met的蛋白表达:收集各分组细胞, 加入稀释过的抗体(小鼠抗人β-actin一抗1∶150、小鼠抗人C-met一抗1:150)4℃孵育过夜, 漂洗后加入辣根过氧化物物酶标记兔抗小鼠二抗, 化学发光法显色, 用目的蛋白C-met A值与内参β-actin A值的比值分析[5]。……

登录APP查看全文

猜你喜欢

胃癌
碘-125粒子调控微小RNA-193b-5p抑制胃癌的增殖和侵袭
青年胃癌的临床特征
胃癌前病变治疗重点是什么?
胃癌组织中PGRN和Ki-67免疫反应性增强
P53及Ki67在胃癌中的表达及其临床意义
胃癌手术治疗效果探讨
胃癌组织中Her-2、VEGF-C的表达及意义
胃癌组织中LKB1和VEGF-C的表达及其意义
胃癌组织中VEGF和ILK的表达及意义
中医辨证结合化疗治疗中晚期胃癌50例